SCHEMBL699273

SCHEMBL699273

O=c1[nH]c2ccccc2n1-c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
AURKA O14965 2/20 0.56
DAO P14920 1/20 0.55
MAPT P10636 1/20 0.54
TNKS O95271 1/20 0.53
HSP90AA1 P07900 4/20 0.53
GAA P10253 2/20 0.52
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
KDM4E B2RXH2 3/20 0.51
POLB P06746 1/20 0.50
PDE7A Q13946 1/20 0.50
PDE7B Q9NP56 1/20 0.50
CYP1A2 P05177 1/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
GABRA1 P14867 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29367625 1.00 LMNA (0.65) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL23119573 0.87 CDK5 (0.59) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL8156714 0.85 GABRP (0.52) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL4098385 0.85 AURKA (0.56) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL23119669 0.85 LMNA (0.67) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL9994946 0.85 HTT (0.56) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL16634744 0.85 L3MBTL1 (0.55) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL18919887 0.84 L3MBTL1 (0.57) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL21463671 0.83 DAO (0.50) LMNAMEN1KMT2AL3MBTL1AURKA
SCHEMBL10743256 0.83 KDM4E (0.73) LMNAMEN1KMT2AL3MBTL1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039409-A2 COMPOSITION COMPRISING ACTIVATORS OF IK POTASSIUM CHANNELS AND CALCINEURIN ANTAGONISTS AND USE THEREOF SWITCH BIOTECH AG (DE) 2004-05-13 WO claimed
US-11802120-B2 Fused cyclic urea derivatives as CRHR2 antagonist RAQUALIA PHARMA INC. (JP) 2023-10-31 US disclosed
US-11802120-B2 Fused cyclic urea derivatives as CRHR2 antagonist RAQUALIA PHARMA INC. (JP) 2023-10-31 US disclosed
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 EP disclosed
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
EP-3356368-B1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO (JP) 2021-07-21 EP disclosed
EP-3356368-B1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO (JP) 2021-07-21 EP disclosed
US-20210078975-A1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2021-03-18 US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 US disclosed
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 EP disclosed
US-5280030-A Containing 1-benz(oxazole, thiazole or imidazole)-4-imidazole piperidine compound SYNTHELABO (FR) 1994-01-18 US disclosed
CN-1065459-A Piperidine derivative and preparation method thereof is used with treatment SYNTHELABO (FR) 1992-10-21 CN disclosed
EP-0507650-A1 Piperidine derivatives, their preparation and their therapeutic application SYNTHELABO (FR) 1992-10-07 EP disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 EP disclosed
US-4377695-A ANTIINFLAMMATORY, ANALGESIC, ANTICOAGULANT AGENTS A. NATTERMANN & CIE GMBH (DE) 1983-03-22 US disclosed
EP-0051827-A1 Omega-(2-oxo-benzimidazolinyl)-alkanoic acid derivatives, process for producing the same and pharmaceutical compounds containing the same A. Nattermann & Cie. GmbH (DE) 1982-05-19 EP disclosed
US-4275215-A QUATERNARY AMMONIUM OR PHOSPHONIUM SALTS CATALYZE REACTION OF HYPOHALITE AND A DIPHENYL UREA DOW CHEMICAL COMPANY LIMITED (GB) 1981-06-23 US disclosed
US-4152434-A ANTIDEPRESSANTS HEXACHIMIE (FR) 1979-05-01 US disclosed
US-4122175-A ANTIDEPRESSANTS HEXACHIMIE (FR) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 LMNA 979/4885MEN1 3653/4885KMT2A 1719/4885
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES KCNH2, KCNH3, KCNJ2 LMNA 979/4885MEN1 3653/4885KMT2A 1719/4885
US-20210078975-A1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST CRHR2, CRHR1, CRH LMNA 3635/4885MEN1 2330/4885KMT2A 4119/4885
US-11802120-B2 Fused cyclic urea derivatives as CRHR2 antagonist CRHR2, CRHR1, CRH LMNA 3635/4885MEN1 2330/4885KMT2A 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.